Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Head & Neck 1

Conditions

Nasopharyngeal Carcinoma 11Squamous Cell Carcinoma of Head and Neck 7Thyroid Neoplasms 2Neoplasm Metastasis 2Nasopharyngeal Neoplasms 2Salivary Gland Malignant Neoplasms 1Recurrence 1Precancerous Conditions 1Mouth Neoplasms 1Locally Advanced Head and Neck Squamous Cell Carcinoma 1Head and Neck Squamous Cell Cancer 1Head and Neck Neoplasms 1

Interventions

Cetuximab 3Biopsy 3Radiotherapy, Intensity-Modulated 2Immunohistochemistry 2Gene Expression Profiling 2Cisplatin 2vandetanib 1sintilimab 1Video-Assisted Surgery 1Photochemotherapy 1Paclitaxel 1Nivolumab 1Dihematoporphyrin Ether 1Comparative Genomic Hybridization 1Celecoxib 1Aspirin 1Aminolevulinic Acid 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precancerous Conditions × sintilimab × Head & Neck × Clear all
NCT04065737 2019-08-22

STOP

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Phase 2 Unknown
29 enrolled
Head & NeckOther neoplasm

Mouth Neoplasms, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡